CD8A and neoplasm: Tumor volume measurements showed that CD8 depletion uncoupled the effect of AR-R17779 treatment in the AR-R17779 + anti-CD8 group, as evidenced by the increased tumor volume after treatment with anti-CD8 antibody (Fig. 8B).